Cadence Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,227	Closed	-$275K	–	634
2016 Q2	$275K	Sell	15,227 -305	-2%	-$5.51K	0.02%	535
2016 Q1	$295K	Hold	15,532	–	–	0.02%	560
2015 Q4	$415K	Buy	+15,532	New	+$415K	0.03%	498